as on January 29, 2026 at 9:37 pm IST
Day's High
1.25%
Upside
52 Week's Low
52 Week's High
24.24%
Downside
54.81%
Upside
Check Bausch Health Companies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.2B
EPS (TTM)
3.9068
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
13.68%
PE Ratio (TTM)
5.98
Industry PE ratio
5.499313725490196
PEG Ratio
0.6315
EBITDA
3.3B
Revenue (TTM)
10.0B
Profit Margin
3.61%
Return On Equity TTM
56.32%
Track how Bausch Health Companies Inc P/E has moved over time to understand its valuation trends.
Bausch Health Companies Inc in the last 5 years
Lowest (1.35x)
June 30, 2025
Industry (5.50x)
January 29, 2026
Today (5.98x)
January 29, 2026
Highest (7.07x)
March 31, 2021
Today’s Price to Earnings Ratio: 5.98x
Compare market cap, revenue, PE, and other key metrics of Bausch Health Companies Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $2.2B | -77.8% | 5.98 | 3.61% | |
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -23.66% | -21.95 | -26.13% |
The Bausch Health Companies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bausch Health Companies Inc investment value today
Current value as on today
₹81,213
Returns
Returns from Bausch Health Companies Inc Stock
Dollar Returns*
₹6,113 (+6.11%)
Based on 10 analysts
0.00%
Buy
60.00%
Hold
40.00%
Sell
Based on 10 analysts, 60% of analysts recommend a 'HOLD' rating for Bausch Health Companies Inc. Average target price of $7.43
Get share price movements and forecasts by analysts on Bausch Health Companies Inc.
What analysts predicted
24.5%UPSIDE
Target Price
$7.43
Current Price
$5.61
Analyzed by
10 Analysts
Target
$7.43
Bausch Health Companies Inc target price $7.43, a slight upside of 24.5% compared to current price of $5.61. According to 10 analysts rating.
Search interest for Bausch Health Companies Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -58.0M → 179.0M (in $), with an average increase of 78.3% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 2.25B → 2.68B (in $), with an average increase of 8.2% per quarter
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 32190.0% return, outperforming this stock by 32214.2%
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3993.0% return, outperforming this stock by 4025.5%
Price Dip
![]()
In the last 7 days, BHC stock has moved down by -13.9%
| Organisation | Bausch Health Companies Inc |
| Headquarters | 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 |
| Industry | Health Technology |
| CEO | Mr. Thomas J. Appio |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jiny Kim M.B.A. | Senior Vice President of Solta Medical |
Mr. Thomas J. Appio | CEO & Director |
Ms. Seana Carson | Executive VP & General Counsel |
Mr. Mirza Dautbegovic | Executive VP & COO |
Mr. Cees Heiman | Senior Vice President of Europe & Canada |
Ms. Kathleen Fitzpatrick | Executive VP and Chief HR & Communications Officer |
Mr. Jean-Jacques Charhon | Executive VP & CFO |
Ms. Aimee J. Lenar | Executive Vice President of US Pharma |
Mr. Steven Lee | Senior VP, Controller & Chief Accounting Officer |
Mr. Garen Sarafian | VP & Head of Investor Relations |
Bausch Health Companies Inc share price today is $5.61 as on . Bausch Health Companies Inc share today touched a day high of $5.68 and a low of $5.61.
Bausch Health Companies Inc share touched a 52 week high of $8.69 on and a 52 week low of $4.25 on . Bausch Health Companies Inc stock price today i.e. is trending at $5.61,which is 35.41% down from its 52 week high and 32.00% up from its 52 week low.
Bausch Health Companies Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Bausch Health Companies Inc (BHC) shares with as little as ₹91.936 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹919.36 in Bausch Health Companies Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bausch Health Companies Inc share’s latest price of $5.61 as on January 29, 2026 at 9:37 pm IST, you will get 1.7825 shares of Bausch Health Companies Inc. Learn more about
fractional shares .
Bausch Health Companies Inc stock has given -77.8% share price returns and 25.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?